Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations

EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - Wiley Online Library
Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …
被引用次数：14 相关文章

Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations

EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Therapeutics exist to treat fibrotic lung disease in adults, but these have not
been investigated in children. Defining biomarkers for pediatric fibrotic lung disease in …

Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations.

EM DeBoer, DR Liptzin, SM Humphries… - Pediatric …, 2021 - europepmc.org
Methods We performed an institutional review board-approved retrospective review of
children with SFTPC dysfunction mutations. We collected demographic and clinical …